Back to search results

Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Recurrent Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (James Eastham, MD)

  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

    Contact: Study coordinator (Neil Fleshner, MD)
    Contact: Study coordinator (Nathan Perlis, MD) · 416-946-4501

  • Skåne University Hospital, Malmö, Skåne County, Sweden

    Contact: Study coordinator (Emelie Winell, RN)
    Contact: Principal Investigator (Anders Bjartell, Prof)

  • Reader in Urology, University College London & Honorary Consultant Urological Surgeon, University College London Hospitals Trust, London, United Kingdom

    Contact: Study coordinator (Caroline Moore, Prof)
    Contact: Study coordinator (Rebecca Scott, RN)
View source on ClinicalTrials.gov(opens in a new tab)